Porphyromonas gingivalis Cell Wall Components Induce Programmed Death Ligand 1 (PD-L1) Expression on Human Oral Carcinoma Cells by a Receptor-Interacting Protein Kinase 2 (RIP2)-Dependent Mechanism

被引:28
|
作者
Groeger, S. [1 ]
Denter, F. [1 ]
Lochnit, G. [2 ,3 ,4 ]
Schmitz, M. L. [2 ,3 ,4 ]
Meyle, J. [1 ]
机构
[1] Justus Liebig Univ Giessen, Dept Periodontol, Giessen, Germany
[2] Inst Biochem, Giessen, Germany
[3] German Ctr Lung Res, Giessen, Germany
[4] Justus Liebig Univ, Giessen, Germany
关键词
PD-L1; B7-H1; Porphyromonas gingivalis; immune evasion; immune suppression; signaling pathway; GASTRIC EPITHELIAL-CELLS; OUTER-MEMBRANE; B7-DC RECEPTORS; T-CELLS; B7-H1; NOD1; INNATE; PEPTIDOGLYCAN; SURAMIN; FAMILY;
D O I
10.1128/IAI.00051-20
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Programmed death-ligand 1 (PD-L1/B7-H1) serves as a cosignaling molecule in cell-mediated immune responses and contributes to chronicity of inflammation and the escape of tumor cells from immunosurveillance. Here, we investigated the molecular mechanisms leading to PD-L1 upregulation in human oral carcinoma cells and in primary human gingival keratinocytes in response to infection with Porphyromonas gingivalis (P. gingivalis), a keystone pathogen for the development of periodontitis. The bacterial cell wall component peptidoglycan uses bacterial outer membrane vesicles to be taken up by cells. Internalized peptidoglycan triggers cytosolic receptors to induce PD-L1 expression in a myeloid differentiation primary response 88 (Myd88)-independent and receptor-interacting serine/threonine-protein kinase 2 (RIP2)-dependent fashion. Interference with the kinase activity of RIP2 or mitogen-activated protein (MAP) kinases interferes with inducible PD-L1 expression.
引用
收藏
页数:13
相关论文
共 45 条
  • [21] Altered Expression of Programmed Death-1 Receptor (PD-1) and Its Ligand PD-L1, PD-L2 after Neo-Adjuvant Chemotherapy in Lung Cancer
    Sun, W.
    Ma, K.
    Wang, X.
    Liu, Y.
    He, H.
    Guo, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1996 - S1996
  • [22] UP-REGULATION OF PROGRAMMED DEATH-L-LIGAND 1 (PD-L1) EXPRESSION AS AN IMMUNE ESCAPE MECHANISM IN CISPLATIN-TREATED HUMAN BLADDER CANCER CELLS
    Hwang, Thomas I.
    Lin, Ji-Fan
    Lin, Yi-Chia
    Tsai, Te-Fu
    Chen, Hung-En
    Chou, Kuang-Yu
    JOURNAL OF UROLOGY, 2018, 199 (04): : E779 - E779
  • [23] Programmed Cell Death 1 Ligand 2 (PD-L2) protein expression is associated with better prognosis in Triple Negative Breast Cancer
    Iqbal, Jabed
    Ong, Clara
    Yeong, Joe
    Li, Huihua
    Lim, Jeffrey Chun Tatt
    Thike, Aye Aye
    Tan, Puay Hoon
    LABORATORY INVESTIGATION, 2019, 99
  • [24] Programmed Cell Death 1 Ligand 2 (PD-L2) protein expression is associated with better prognosis in Triple Negative Breast Cancer
    Iqbal, Jabed
    Ong, Clara
    Yeong, Joe
    Li, Huihua
    Lim, Jeffrey Chun Tatt
    Thike, Aye Aye
    Tan, Puay Hoon
    MODERN PATHOLOGY, 2019, 32
  • [25] Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III/IV lung squamous cell carcinoma (SQC)
    Guo, Qinxiang
    Sun, Yu
    Yu, Sifan
    Bai, Hua
    Zhao, Jun
    Zhuo, Minglei
    Wang, Jie
    THORACIC CANCER, 2017, 8 (02) : 73 - 79
  • [26] Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
    Darb-Esfahani, Silvia
    Kunze, Catarina Alisa
    Kulbe, Hagen
    Sehouli, Jalid
    Wienert, Stephan
    Lindner, Judith
    Budczies, Jan
    Bockmayr, Michael
    Dietel, Manfred
    Denkert, Carsten
    Braicu, Ioana
    Joehrens, Korinna
    ONCOTARGET, 2016, 7 (02) : 1486 - 1499
  • [27] C-X-C chemokine receptor 2 (Cxcr2) promotes hepatocellular carcinoma immune evasion via regulating programmed death-ligand 1 (PD-L1)
    Wan, Yafeng
    Ge, Ke
    Zhou, Weijiang
    Lu, Jun
    Jia, Changku
    Zhu, Hanzhang
    BIOLOGICAL CHEMISTRY, 2021, 402 (06) : 729 - 737
  • [28] Targeting PD-L1 (Programmed death-ligand 1) and inhibiting the expression of IGF2BP2 (Insulin-like growth factor 2 mRNA-binding protein 2) affect the proliferation and apoptosis of hypopharyngeal carcinoma cells
    Yang, Xudong
    Liu, Jisheng
    BIOENGINEERED, 2021, 12 (01) : 7755 - 7764
  • [29] Expression of Immune Checkpoint Regulator Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) and Programmed Cell Death Protein Ligand 1 (PD-L1) in Invasive Ductal Carcinoma Breast
    Diwaker, Preeti
    Jha, Tanvi
    Gogoi, Priyanka
    Arora, Vinod Kumar
    Ansari, Mohammad Ahmad
    Kaur, Navneet
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (04) : 713 - 720
  • [30] Correlation of tumor programmed death ligand-1 (PD-L1) expression and response to treatment with high-dose interleukin-2 (HD IL-2) in clear cell metastatic renal cell carcinoma (ccmRCC).
    Crispin, Hilda
    Agarwal, Archana M.
    Salama, Mohamed E.
    Tantravahi, Srinivas Kiran
    Merriman, Joseph
    Straubhar, Alli M.
    Poole, Austin
    Nussenzvelg, Roberto
    Stenehjem, David I.
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)